Persistence of protective immunity following vaccination against tick-borne encephalitis - longer than expected?

被引:51
作者
Rendi-Wagner, P
Kundi, A
Zent, O
Dvorak, G
Jaehnig, P
Holzmann, H
Mikolasek, A
Kollaritsch, H
机构
[1] Univ Vienna, Inst Pathophysiol, Dept Specif Prophylaxis & Trop Med, A-1095 Vienna, Austria
[2] Univ Vienna, Inst Environm Hlth, A-1095 Vienna, Austria
[3] Chiron Vaccines, Clin Res & Med Affairs, D-35006 Marburg, Germany
[4] Univ Vienna, Inst Virol, A-1095 Vienna, Austria
关键词
tick-borne encephalitis vaccination; protective immunity; antibody persistence;
D O I
10.1016/j.vaccine.2004.01.041
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A descriptive evaluation of protective immunity was performed on subjects with a complete primary tick-borne encephalitis (TBE) immunization (and additional regular boosters) more than 3 years after primary or booster TBE immunization, as measured by neutralization test and two different ELISA systems. The study population (n = 430) was stratified for age (i.e., 18-49 or 50 years of age) and for the number of years since last TBE vaccination. GMTs (NT) of all subgroups (at the time of the present evaluation) were above detection limit: 144 and 44 for the 18-49- and 50-year-old subjects, respectively. One percent of subjects aged 18-49 years, and 6% of subjects aged 50 years were ELISA-negative. A detailed sub analysis revealed that subjects with either low NT and/or negative to borderline ELISA test results are usually older and constitute a higher number of subjects without any TBE booster vaccination compared to the respective test-positive subject group. From the fourth year (exceeding 3 years after last vaccination) titers show a decline rate of 6-7%. This study indicates that after multiple TBE (booster) immunizations protection surpasses the currently advised TBE booster interval of 3 years, thus supporting reconsideration of the recommendations for booster intervals. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2743 / 2749
页数:7
相关论文
共 26 条
[1]   GENETIC PREDICTION OF NONRESPONSE TO HEPATITIS-B VACCINE [J].
ALPER, CA ;
KRUSKALL, MS ;
MARCUSBAGLEY, D ;
CRAVEN, DE ;
KATZ, AJ ;
BRINK, SJ ;
DIENSTAG, JL ;
AWDEH, Z ;
YUNIS, EJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (11) :708-712
[2]  
BARRET PN, 2003, VACCINE, V21
[3]  
DITTMANN S, 1998, TICK BORNE ENCEPHALI
[4]   Costimulatory mechanisms in the elderly [J].
Effros, RB .
VACCINE, 2000, 18 (16) :1661-1665
[5]  
HOLLINGER FB, 1989, AM J MED, V87, pS36
[6]  
Holzmann H, 1996, J MED VIROL, V48, P102, DOI 10.1002/(SICI)1096-9071(199601)48:1&lt
[7]  
102::AID-JMV16&gt
[8]  
3.0.CO
[9]  
2-I
[10]   Diagnosis of tick-borne encephalitis [J].
Holzmann, H .
VACCINE, 2003, 21 :S36-S40